PREVENT AND PROTECT: NSW POLITICAL CANDIDATES OUTLINE POLICY PRIORITIES IN GREAT HEALTH DEBATE co-hosted by PHAA NSW Branch & University of Sydney’s School of Public Health
With
Anita Dessaix, NSW Branch President
Public Health Association of Australia &
Director of Cancer Prevention & Advocacy
Cancer Council NSW
Professor Camille Raynes-Greenow,
Deputy Associate Dean (Research),
Faculty of Medicine and Health,
University of Sydney
SEGMENT
Filmed in Sydney | October 2026
Heading towards NSW State Election in March 2027, the NSW Health Minister, Shadow Minister for Health and Greens Health spokesperson met to debate one another this week – laying out their vision of how they would protect the health of NSW residents and use prevention to reduce demand on NSW hospitals, doctors and ambulances.
Held on 1 October and co-hosted by the Public Health Association of Australia NSW Branch and the University of Sydney’s School of Public Health, the debate examined how NSW can reduce pressure on hospitals and health services by addressing health risks before they develop into serious illness.
The discussion highlighted priorities including obesity, tobacco control, climate change, gambling, health inequities and the broader social determinants of health. Speakers also emphasised the need for sustained investment in prevention rather than relying solely on expanding hospital and clinical capacity.
Anita Dessaix, NSW Branch President of the Public Health Association of Australia, told Australian Health Journal that a key priority is for the next NSW Government to commit to a long-term preventative health strategy.
“One of our critical policy asks is for the next NSW Government to introduce a five-year New South Wales Preventative Health Strategy.”
Professor Camille Raynes-Greenow, Deputy Associate Dean (Research) at the University of Sydney, also highlighted the importance of prevention and research-informed policy.
Speaking in her interview with Australian Health Journal, she said: “Ultimately, I’d really like to see a much stronger focus on prevention.”
The debate reinforced the growing focus on prevention as a critical component of a sustainable NSW health system.
POLITICAL CANDIDATES IN GREAT HEALTH DEBATE
- The Hon. Ryan Park MP, NSW Minister for Health, Minister for Regional Health,
- The Hon. Sarah Mitchell MLC, Shadow Minister for Health, Shadow Minister for Regional Health, and Shadow Minister for Mental Health
- Dr Amanda Cohn MLC, a Member of the NSW Legislative Council, and the NSW Greens spokesperson for Health.
Source: Adapted from PHAA media release (September, 2026) & transcript
-
From refugee to receiving multiple accolades as a community pharmacist
Sara is an experienced pharmacist, community health advocate, and the Lead Pharmacist at Pharmacy 777 Pascoe Vale in Victoria. With over 20 years in the profession, Sara has played a significant role in advancing local healthcare delivery through clinical leadership, service development, and strong community partnerships.
-
State of private healthcare in Australia
Australia’s healthcare system is often described as a mixed system, with a combination of public and private providers. While public healthcare through Medicare provides universal coverage for essential services, private healthcare offers additional options and amenities for those who can afford them.
Private Healthcare Australia (PHA) is the Australian private health insurance industry’s peak representative body that currently has 21registered health funds throughout Australia and collectively represents 98% of people covered by private health insurance. PHA member funds today provide healthcare benefits for over 14 million Australians.
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
